Cargando…

Effectiveness of Automated Insulin Management Features of the MiniMed(®) 640G Sensor-Augmented Insulin Pump

Background: Automated insulin management features of the MiniMed(®) 640G sensor-augmented pump system include suspension in response to predicted low sensor glucose (SG) values (“suspend before low”), suspension in response to existing low SG values (“suspend on low”), and automatic restarting of ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Alex, Choudhary, Pratik, McMahon, Chantal, Agrawal, Pratik, Welsh, John B., Cordero, Toni L., Kaufman, Francine R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111481/ https://www.ncbi.nlm.nih.gov/pubmed/27672710 http://dx.doi.org/10.1089/dia.2016.0216

Ejemplares similares

The Effectiveness of Virtual Training on the MiniMed™ 670G System in People with Type 1 Diabetes During the COVID-19 Pandemic
por: Vigersky, Robert A., et al.
Publicado: (2021)

Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management
por: Choudhary, Pratik, et al.
Publicado: (2016)

Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk
por: Choudhary, Pratik, et al.
Publicado: (2011)

Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care
por: Avari, Parizad, et al.
Publicado: (2022)

MON-640 Endogenous Insulin and C-Peptide Suppression Test Using a Rapid-Acting Insulin Analog in the Diagnosis of Insulinoma
por: Laotaveerungrueng, Nattapong, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017)

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
por: Forlenza, Gregory P., et al.
Publicado: (2019)

Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
por: Schiavon, Michele, et al.
Publicado: (2014)

Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment
por: Ortolani, Federica, et al.
Publicado: (2015)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy
por: Ly, Trang T., et al.
Publicado: (2012)

Medtronic MiniMed 670G Hybrid Closed-Loop System
por: Knebel, Tory, et al.
Publicado: (2019)

OR30-01 Real-World Minimed™ 670G System Use and Glycemic Outcomes of Pediatric and Adult Individuals Living with Type 1 Diabetes (T1D) in the United States
por: Vigersky, Robert Alan, et al.
Publicado: (2020)

Long-term efficacy of sensor-augmented pump therapy (Minimed 640G system) combined with a telemedicine follow-up in patients with type 1 diabetes: A real life study
por: Notemi, Léonie Makuété, et al.
Publicado: (2022)

Use of fast‐acting insulin aspart in insulin pump therapy in clinical practice
por: Evans, Mark, et al.
Publicado: (2019)

A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
por: Forst, Thomas, et al.
Publicado: (2020)

Cisco CCNA/CCENT Exam 640-802, 640-822, 640-816 Preparation Kit: With Cisco Router Simulations
por: Liu, Dale
Publicado: (2009)

Medtronic MiniMed 670G Auto Mode: Implications for Clinical Practice
por: Dos Santos-Marinho, Jeanne, et al.
Publicado: (2021)

Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users
por: Arrieta, Arcelia, et al.
Publicado: (2022)

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
por: Roze, Stephané, et al.
Publicado: (2019)

Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy
por: Hussain, Tara, et al.
Publicado: (2017)

Redesigning an intensive insulin service for patients with type 1 diabetes: a patient consultation exercise
por: Ozcan, Seyda, et al.
Publicado: (2013)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Advantages of sensor‐augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus
por: Imafuku, Hitomi, et al.
Publicado: (2023)

Insulin Augmentation of Glucose-Stimulated Insulin Secretion Is Impaired in Insulin-Resistant Humans
por: Halperin, Florencia, et al.
Publicado: (2012)

Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
por: Cordero, Toni L., et al.
Publicado: (2023)

Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump
por: Thrasher, James, et al.
Publicado: (2018)

Insulin pump exposed to radioactive iodine
por: Magdaleno, Angela L., et al.
Publicado: (2018)

Why you should Mini-Med School: Mini-Med School as an intervention to increase health literacy
por: Shatenko, Sergiy, et al.
Publicado: (2020)

Olivetti M6 640
Publicado: (1993)

Insulin Edema With Use of U-500 Regular Insulin in a Hybrid Closed-Loop Insulin Pump
por: Vasigh, Mostafa, et al.
Publicado: (2020)

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy
por: Zisser, Howard C.
Publicado: (2010)

Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps
por: Holterhus, Paul-Martin, et al.
Publicado: (2013)

The relationship between different C-peptide level and insulin dose of insulin pump
por: Wei, Yihan, et al.
Publicado: (2021)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
por: Carlson, Anders L., et al.
Publicado: (2022)

Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial
por: Moreno-Fernandez, Jesus, et al.
Publicado: (2016)

The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes
por: Lee, Yun Jeong, et al.
Publicado: (2020)

An Overview of Insulin Pumps and Glucose Sensors for the Generalist
por: McAdams, Brooke H., et al.
Publicado: (2016)

Insulin pumps in children - a systematic review
por: Al-Beltagi, Mohammed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tvf97a41qbpaku0hu7c3a3b9g5